Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
The Lancet. Diabetes & Endocrinology|February 4, 2023
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trialLori M Laffel, Thomas Danne, Georgeanna J Klingensmith, et al.Journal of Clinical & Translational Endocrinology|May 23, 2022
ZnT8 autoantibody prevalence is low in youth with type 2 diabetes and associated with higher insulin sensitivity, lower insulin secretion, and lower disposition indexJanine Higgins, Philip Zeitler, Kimberly L Drews, et al.Clinical Journal of the American Society of Nephrology : CJASN|November 28, 2025
Impact of Empagliflozin on Glomerular Hyperfiltration and Albuminuria in Youth with Type 2 Diabetes: Post-Hoc Analysis of DINAMOPetter Bjornstad, Thomas Danne, Georgeanna J Klingensmith, et al.Pediatric Allergy, Immunology, and Pulmonology|October 25, 2017
Adrenal Insufficiency in Pediatric Eosinophilic Esophagitis Patients Treated with Swallowed Topical SteroidsStephanie Hsu, Colleen Wood, Zhaoxing Pan, et al.The Journal of Clinical Endocrinology and Metabolism|September 24, 2019
Body Composition and Markers of Cardiometabolic Health in Transgender Youth Compared With Cisgender YouthNatalie J Nokoff, Sharon L Scarbro, Kerrie L Moreau, et al.The Journal of Clinical Endocrinology and Metabolism|April 29, 2022
Deterioration of Glycemic Control in Youth-Onset Type 2 Diabetes: What Are the Early and Late Predictors?Philip Zeitler, Laure El Ghormli, Silva Arslanian, et al.The New England Journal of Medicine|July 28, 2021
Long-Term Complications in Youth-Onset Type 2 Diabetes, Petter Bjornstad, Kimberly L Drews, et al.Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Testosterone Effects on Short-Term Physical, Hormonal, and Neurodevelopmental Outcomes in Infants with 47,XXY/Klinefelter Syndrome: The TESTO Randomized Controlled TrialShanlee Davis, Susan Howell, Jennifer Janusz, et al.Transgender Health|May 3, 2021
Body Composition and Markers of Cardiometabolic Health in Transgender Youth on Gonadotropin-Releasing Hormone AgonistsNatalie J Nokoff, Sharon L Scarbro, Kerrie L Moreau, et al.Journal of Clinical & Translational Endocrinology|July 1, 2024
Insulin sensitivity, body composition and bone mineral density after testosterone treatment in transgender youth with and without prior GnRH agonist therapyNatalie J Nokoff, Samantha Bothwell, John D Rice, et al.Pageof 5